cefazolin , a new cephalosporin derivative , was studied in the treatment of 105 hospitalized patients with a variety of infections including endocarditis , pneumonia , and urinary and soft tissue infections , and was found to be effective in 104 patients .
C0007546
cefazolin
C0149778
soft tissue infections